Capital Performance Advisors’s Qiagen QGEN Stock Holding History

Capital Performance Advisors’s Portfolio QGEN Stock Details QGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-6	Closed	-$273	–	2065
2024 Q3	$273	Buy	+6	New	+$274	﹤0.01%	2485

Other funds holding QGEN

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

Nuance Investments Kansas City, Missouri $717M AUM 3.8% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Performance Advisors's QGEN Position: Q4 2024 in Review

Capital Performance Advisors sold out of Qiagen (QGEN) in Q4 2024, closing a stake of 6 shares — an estimated $273 sold.

Capital Performance Advisors first reported a position in QGEN in Q3 2024 and held it in 1 quarter. The position peaked at $273 in Q3 2024. 324 funds tracked by Wall St. Rank hold QGEN as of Q4 2024.

Capital Performance Advisors reported no remaining Qiagen position as of Q4 2024 after selling out during the quarter.
Capital Performance Advisors sold 6 Qiagen shares in Q4 2024, an estimated $273.
Capital Performance Advisors first reported a position in Qiagen in Q3 2024 and held it in 1 quarter.
Capital Performance Advisors's Qiagen position peaked at $273 in Q3 2024.
324 funds tracked by Wall St. Rank held Qiagen as of Q4 2024.

Based on Capital Performance Advisors's 13F filing for Q4 2024, filed 31 Jan 2025.